Gunderson Dettmer represented Petal on the deal. Petal, a modern credit card distributor, announced its $35 million strategic financing led by Valar Ventures. Petal offers three Visa...
Petal’s $35 Million Strategic Financing
Orbital Therapeutics’ $270M Series Financing
Gunderson Dettmer represented ARCH Venture Partners on the deal. ARCH Venture Partners led the $270 million Series A financing of Orbital Therapeutics, a company focused on enhancing...
Replit’s $97.4 Million Series B Extension Financing
Gunderson Dettmer represented Andreessen Horowitz on the deal. Andreessen Horowitz led the $97.4 million Series B extension financing of Replit, the world’s fastest-growing developer platform and...
Kala’s $6 Million Series Seed Financing
Gunderson Dettmer represented Kala on the deal. Kala, a Colombia-based company building fintech infrastructure for lending, announced its $6 million Series Seed financing. Kala’s vertical SaaS product is...
Brassica Technologies’ $8 Million Seed Financing
Gunderson Dettmer represented Mercury on the deal. Mercury led the $8 million Seed financing of Brassica Technologies, an investment infrastructure for private securities and digital assets....
Teamworks’ $65 Million Series E Financing
Gunderson Dettmer represented Dragoneer Investment Group on the deal. Dragoneer Investment Group led the $65 million Series E financing of Teamworks, an enterprise SaaS company serving...
ClimateAi’s $22 Million Series B Financing
Gunderson Dettmer represented ClimateAi on the deal. ClimateAi, a climate resilience platform, announced its $22 million Series B financing led by Four Rivers Group, with participation from...
Rock The Bells’ $15 Million Series B Financing
Gunderson Dettmer advised Raine Ventures on the deal. Raine Ventures announced its participation of the $15 million Series B financing of Rock The Bells, a hip...
Pipeline Therapeutics’ Global License and Development Agreement with Janssen
Gunderson Dettmer represented Pipeline Therapeutics on the deal. Pipeline Therapeutics, a clinical-stage biopharmaceutical company, entered into a global license and development agreement with Janssen Pharmaceutica NV...
Semgrep’s $53 Million Series C financing
Gunderson Dettmer represented Semgrep on the deal. Semgrep, a code and supply chain security search engine, announced its $53 million Series C financing led by Lightspeed Venture Partners...
Coro’s $75 Million Series C-2 Financing
Gunderson Dettmer represented Energy Impact Partners on the deal. Energy Impact Partners acted as the single investor in the $75 million Series C-2 financing of Coro,...
Abdera’s $142 Million Financing
Fenwick represented Abdera Therapeutics on the deal. Abdera Therapeutics, a biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable, precision radiopharmaceuticals...